Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 15, 2009

Zymeworks and XOMA Collaborate on Antibody Optimization

  • Zymeworks entered into a research agreement with XOMA to optimize an antibody. The partnership will leverage Zymeworks’ ZymeCAD™ suite of predictive protein engineering tools and XOMA’s Targeted Affinity Enhancement™ technology.

    ZymeCAD molecular simulation platform creates a modeling environment that generates novel physical and chemical insights into protein systems, according to Zymeworks.


Related content

  • You’re all set! Thank you for subscribing to GEN Highlights.